CompanyDrug

Hansoh Pharmaceutical Advances Schizophrenia Treatment with HS-10509 Clinical Trial Approval

CompanyDrug

Sino Biopharmaceutical Receives NMPA Approval for Generic Revolade Equivalent

CompanyDrug

Luye Pharma’s Biosimilar Bevacizumab Gets GMP Certification in Brazil

CompanyDrug

Regenxbio’s One-Time Gene Therapy for Wet AMD Shows Promise in Phase II Study

CompanyDrug

Takeda’s Hyqvia Approved by FDA for Chronic Inflammatory Demyelinating Polyneuropathy

Policy / Regulatory

China Regulators Chart Steady Path for ‘Huiminbao’ Medical Insurance Schemes

CompanyDrug

Qilu Pharmaceutical’s Iruplinalkib Gains Additional Indication Approval in China for ALK-Positive NSCLC

CompanyDrug

Changchun High & New Technology Industries to Launch GenSci125 Phase I Trial in US

CompanyDrug

Hengrui Pharmaceuticals Receives NMPA Approval for Phase II Cervical Cancer Study

CompanyDrug

Roche’s Tecentriq SC Receives European Nod as First Subcutaneous PD-(L)1 Therapy

CompanyDrug

Sino Biopharmaceutical Commences Phase III Trial for Semaglutide Biosimilar in China

CompanyDeals

Ocumension Therapeutics Sells $56.66 Million Stake in EyePoint Pharmaceuticals